Properdin provides protection from Citrobacter rodentium-induced intestinal inflammation in a C5a/IL-6-dependent manner

Journal of Immunology

Volumn 194, Issue 7, 2015, Pages 3414-3421

  Jain, Umang ^a   Cao, Qi ^a   Thomas, Nikhil A ^a   Woodruff, Trent M ^b   Schwaeble, Wilhelm J ^c   Stover, Cordula M ^c   Stadnyk, Andrew W ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; INTERLEUKIN 6; PROPERDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; CITROBACTER RODENTIUM; COLITIS; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIARRHEA; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; ENTEROBACTERIACEAE INFECTION; EPITHELIUM CELL; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; CELL LINE; DISEASE COURSE; DISEASE MODEL; ENTERITIS; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

ANIMALS; CELL LINE; CITROBACTER RODENTIUM; COMPLEMENT C5A; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENTERITIS; ENTEROBACTERIACEAE INFECTIONS; INTERLEUKIN-6; INTESTINAL MUCOSA; MICE; MICE, KNOCKOUT; PROPERDIN;

EID: 84925862803     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401814     Document Type: Article

References (51)

1. Kaper, J. B., J. P. Nataro, and H. L. Mobley. 2004. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2: 123-140.
2. Nataro, J. P., and J. B. Kaper. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11: 142-201.
3. Borenshtein, D., M. E. McBee, and D. B. Schauer. 2008. Utility of the Citrobacter rodentium infection model in laboratory mice. Curr. Opin. Gastroenterol. 24: 32-37.
4. Mundy, R., T. T. MacDonald, G. Dougan, G. Frankel, and S. Wiles. 2005. Citrobacter rodentium of mice and man. Cell. Microbiol. 7: 1697-1706.
5. Croxen, M. A., and B. B. Finlay. 2010. Molecular mechanisms of Escherichia coli pathogenicity. Nat. Rev. Microbiol. 8: 26-38.
6. Eckmann, L. 2006. Animal models of inflammatory bowel disease: lessons from enteric infections. Ann. N. Y. Acad. Sci. 1072: 28-38.
7. Barthold, S. W. 1979. Autoradiographic cytokinetics of colonic mucosal hyperplasia in mice. Cancer Res. 39: 24-29.
8. Lebeis, S. L., B. Bommarius, C. A. Parkos, M. A. Sherman, and D. Kalman. 2007. TLR signaling mediated by MyD88 is required for a protective innate immune response by neutrophils to Citrobacter rodentium. J. Immunol. 179: 566-577.
9. Liu, Z., M. H. Zaki, P. Vogel, P. Gurung, B. B. Finlay, W. Deng, M. Lamkanfi, and T. D. Kanneganti. 2012. Role of inflammasomes in host defense against Citrobacter rodentium infection. J. Biol. Chem. 287: 16955-16964.
10. Klos, A., A. J. Tenner, K. O. Johswich, R. R. Ager, E. S. Reis, and J. Köhl. 2009. The role of the anaphylatoxins in health and disease. Mol. Immunol. 46: 2753-2766.
11. Dunkelberger, J. R., and W. C. Song. 2010. Complement and its role in innate and adaptive immune responses. Cell Res. 20: 34-50.
12. Belzer, C., Q. Liu, M. C. Carroll, and L. Bry. 2011. The role of specific IgG and complement in combating a primary mucosal infection of the gut epithelium. Eur. J. Microbiol. Immunol. (Bp) 1: 311-318.
13. Medicus, R. G., O. Götze, and H. J. Müller-Eberhard. 1976. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway. J. Exp. Med. 144: 1076-1093.
14. Pillemer, L., L. Blum, I. H. Lepow, O. A. Ross, E. W. Todd, and A. C. Wardlaw. 1954. The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science 120: 279-285.
15. Smith, C. A., M. K. Pangburn, C. W. Vogel, and H. J. Müller-Eberhard. 1984. Molecular architecture of human properdin, a positive regulator of the alternative pathway of complement. J. Biol. Chem. 259: 4582-4588.
16. Spitzer, D., L. M. Mitchell, J. P. Atkinson, and D. E. Hourcade. 2007. Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly. J. Immunol. 179: 2600-2608.
17. Harboe, M., and T. E. Mollnes. 2008. The alternative complement pathway revisited. J. Cell. Mol. Med. 12: 1074-1084.
18. Lutz, H. U., and E. Jelezarova. 2006. Complement amplification revisited. Mol. Immunol. 43: 2-12.
19. Ali, Y. M., A. Hayat, B. M. Saeed, K. S. Haleem, S. Alshamrani, H. I. Kenawy, V. P. Ferreira, G. Saggu, A. Buchberger, P. J. Lachmann, et al. 2014. Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and Neisseria meningitidis infection. Proc. Natl. Acad. Sci. USA 111: 5301-5306.
20. Stover, C. M., J. C. Luckett, B. Echtenacher, A. Dupont, S. E. Figgitt, J. Brown, D. N. Männel, and W. J. Schwaeble. 2008. Properdin plays a protective role in polymicrobial septic peritonitis. J. Immunol. 180: 3313-3318.
21. Bergstrom, K. S., V. Kissoon-Singh, D. L. Gibson, C. Ma, M. Montero, H. P. Sham, N. Ryz, T. Huang, A. Velcich, B. B. Finlay, et al. 2010. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog. 6: e1000902.
22. Jain, U., T. M. Woodruff, and A. W. Stadnyk. 2013. The C5a receptor antagonist PMX205 ameliorates experimentally induced colitis associated with increased IL-4 and IL-10. Br. J. Pharmacol. 168: 488-501.
23. Cao, Q., S. M. McIsaac, and A. W. Stadnyk. 2012. Human colonic epithelial cells detect and respond to C5a via apically expressed C5aR through the ERK pathway. Am. J. Physiol. Cell Physiol. 302: C1731-C1740.
24. Dann, S. M., M. E. Spehlmann, D. C. Hammond, M. Iimura, K. Hase, L. J. Choi, E. Hanson, and L. Eckmann. 2008. IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens. J. Immunol. 180: 6816-6826.
25. Di Sabatino, A., R. Ciccocioppo, O. Luinetti, L. Ricevuti, R. Morera, M. G. Cifone, E. Solcia, and G. R. Corazza. 2003. Increased enterocyte apoptosis in inflamed areas of Crohn's disease. Dis. Colon Rectum 46: 1498-1507.
26. Günther, C., H. Neumann, M. F. Neurath, and C. Becker. 2013. Apoptosis, necrosis and necroptosis: cell death regulation in the intestinal epithelium. Gut 62: 1062-1071.
27. Simmons, C. P., N. S. Goncalves, M. Ghaem-Maghami, M. Bajaj-Elliott, S. Clare, B. Neves, G. Frankel, G. Dougan, and T. T. MacDonald. 2002. Impaired resistance and enhanced pathology during infection with a noninvasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-γ. J. Immunol. 168: 1804-1812.
28. Gonc¸alves, N. S., M. Ghaem-Maghami, G. Monteleone, G. Frankel, G. Dougan, D. J. Lewis, C. P. Simmons, and T. T. MacDonald. 2001. Critical role for tumor necrosis factor alpha in controlling the number of lumenal pathogenic bacteria and immunopathology in infectious colitis. Infect. Immun. 69: 6651-6659.
29. Dann, S. M., C. Le, B. K. Choudhury, H. Liu, O. Saldarriaga, E. M. Hanson, Y. Cong, and L. Eckmann. 2014. Attenuation of intestinal inflammation in interleukin-10-deficient mice infected with Citrobacter rodentium. Infect. Immun. 82: 1949-1958.
30. Geddes, K., S. J. Rubino, J. G. Magalhaes, C. Streutker, L. Le Bourhis, J. H. Cho, S. J. Robertson, C. J. Kim, R. Kaul, D. J. Philpott, and S. E. Girardin. 2011. Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nat. Med. 17: 837-844.
31. Rubino, S. J., K. Geddes, and S. E. Girardin. 2012. Innate IL-17 and IL-22 responses to enteric bacterial pathogens. Trends Immunol. 33: 112-118.
32. Pagano, M. B., H. F. Zhou, T. L. Ennis, X. Wu, J. D. Lambris, J. P. Atkinson, R. W. Thompson, D. E. Hourcade, and C. T. Pham. 2009. Complement-dependent neutrophil recruitment is critical for the development of elastase-induced abdominal aortic aneurysm. Circulation 119: 1805-1813.
33. Zhou, H. F., H. Yan, C. M. Stover, T. M. Fernandez, S. Rodriguez de Cordoba, W. C. Song, X. Wu, R. W. Thompson, W. J. Schwaeble, J. P. Atkinson, et al. 2012. Antibody directs properdin-dependent activation of the complement alternative pathway in a mouse model of abdominal aortic aneurysm. Proc. Natl. Acad. Sci. USA 109: E415-E422.
34. Ricklin, D., G. Hajishengallis, K. Yang, and J. D. Lambris. 2010. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 11: 785-797.
35. Jain, U., A. R. Otley, J. Van Limbergen, and A. W. Stadnyk. 2014. The complement system in inflammatory bowel disease. Inflamm. Bowel Dis. 20: 1628-1637.
36. Dupont, A., F. Mohamed, N. Salehen, S. Glenn, L. Francescut, R. Adib, S. Byrne, H. Brewin, I. Elliott, L. Richards, et al. 2014. Septicaemia models using Streptococcus pneumoniae and Listeria monocytogenes : understanding the role of complement properdin. Med. Microbiol. Immunol. (Berl.) 203: 257-271.
37. Ivanovska, N. D., P. A. Dimitrova, J. C. Luckett, R. El-Rachkidy Lonnen, W. J. Schwaeble, and C. M. Stover. 2008. Properdin deficiency in murine models of nonseptic shock. J. Immunol. 180: 6962-6969.
38. Kimura, Y., L. Zhou, T. Miwa, and W. C. Song. 2010. Genetic and therapeutic targeting of properdin in mice prevents complement-mediated tissue injury. J. Clin. Invest. 120: 3545-3554.
39. Ruseva, M. M., K. A. Vernon, A. M. Lesher, W. J. Schwaeble, Y. M. Ali, M. Botto, T. Cook, W. Song, C. M. Stover, and M. C. Pickering. 2013. Loss of properdin exacerbates C3 glomerulopathy resulting from factor H deficiency. J. Am. Soc. Nephrol. 24: 43-52.
40. Li, L., Q. G. Shi, F. Lin, Y. G. Liang, L. J. Sun, J. S. Mu, Y. G. Wang, H. B. Su, B. Xu, C. C. Ji, et al. 2014. Cytokine IL-6 is required in Citrobacter rodentium infection-induced intestinal Th17 responses and promotes IL-22 expression in inflammatory bowel disease. Mol Med Rep 9: 831-836.
41. Cartun, R. W., H. J. Van Kruiningen, C. A. Pedersen, and M. M. Berman. 1993. An immunocytochemical search for infectious agents in Crohn's disease. Mod. Pathol. 6: 212-219.
42. Liu, Y., H. J. van Kruiningen, A. B. West, R. W. Cartun, A. Cortot, and J. F. Colombel. 1995. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology 108: 1396-1404.
43. Klos, A., E. Wende, K. J. Wareham, and P. N. Monk. 2013. International Union of Basic and Clinical Pharmacology. LXXXVII. Complement peptide C5a, C4a, and C3a receptors. Pharmacol. Rev. 65: 500-543.
44. Woodruff, T. M., T. V. Arumugam, I. A. Shiels, R. C. Reid, D. P. Fairlie, and S. M. Taylor. 2003. A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel disease. J. Immunol. 171: 5514-5520.
45. Woodruff, T. M., S. Pollitt, L. M. Proctor, S. Z. Stocks, H. D. Manthey, H. M. Williams, I. B. Mahadevan, I. A. Shiels, and S. M. Taylor. 2005. Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease. J. Pharmacol. Exp. Ther. 314: 811-817.
46. Chen, G., Y. Yang, X. Gao, Y. Dou, H. Wang, G. Han, R. Wang, J. Wang, L. Wang, X. Li, et al. 2011. Blockade of complement activation product C5a activity using specific antibody attenuates intestinal damage in trinitrobenzene sulfonic acid induced model of colitis. Lab. Invest. 91: 472-483.
47. Gay, J., E. Kokkotou, M. O'Brien, C. Pothoulakis, and K. P. Karalis. 2006. Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines. Neuroimmunomodulation 13: 114-121.
48. Yamamoto, M., K. Yoshizaki, T. Kishimoto, and H. Ito. 2000. IL-6 is required for the development of Th1 cell-mediated murine colitis. J. Immunol. 164: 4878-4882.
49. Harboe, M., G. Ulvund, L. Vien, M. Fung, and T. E. Mollnes. 2004. The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation. Clin. Exp. Immunol. 138: 439-446.
50. Amara, U., D. Rittirsch, M. Flierl, U. Bruckner, A. Klos, F. Gebhard, J. D. Lambris, and M. Huber-Lang. 2008. Interaction between the coagulation and complement system. Adv. Exp. Med. Biol. 632: 71-79.
51. Lake, A. M., A. E. Stitzel, J. R. Urmson, W. A. Walker, and R. E. Spitzer. 1979. Complement alterations in inflammatory bowel disease. Gastroenterology 76: 1374-1379.